Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-i: Methotrexate Auto-injector vs Syringe in Rheumatoid Arthritis
NCT02553018Phase 3Completed
- Sponsor
- Nordic Pharma
- Start
- Sep 2015
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in rheumatoid arthritis (RA), sponsored by Nordic Pharma. Started Sep 2015; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02553018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02553018.